Dimethyl Fumarate Ameliorates Disease Severity in a Mouse Model of Chronic Graft-Versus-Host Disease.

被引：0
|
作者：
Assmann, Julian C. [1 ]
Warrick, Kathrynne [1 ]
Johns, Christopher [1 ]
Farthing, Don E. [1 ]
Gress, Ronald E. [1 ]
Buxbaum, Nataliya P. [1 ]
机构：
[1] NCI, Expt Transplantat & Immunol Branch, Bethesda, MD 20892 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2020年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
242
引用
收藏
页码：S167 / S168
页数：2
相关论文
共 50 条
  • [1] Hepatocyte growth factor ameliorates chronic graft-versus-host disease.
    Imado, T
    Iwasaki, T
    Kuroiwa, T
    Okamoto, T
    Hara, H
    Sano, H
    BLOOD, 2004, 104 (11) : 831A - 831A
  • [2] Blockade of Syk Ameliorates the Development of Sclerodermatous Chronic Graft-Versus-Host Disease.
    Matsushita, T.
    Le Huu, D.
    Kimura, H.
    Date, M.
    Hamaguchi, Y.
    Hasegawa, M.
    Fujimoto, M.
    Takehara, K.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S3 - S3
  • [3] Dimethyl fumarate ameliorates chronic graft-versus-host disease by inhibiting Tfh differentiation via Nrf2
    Lyu, Fulian
    Gong, Huanle
    Wu, Xiaojin
    Liu, Xin
    Lu, Yinghao
    Wei, Xiya
    Liu, Chenchen
    Shen, Yaoyao
    Wang, Yuhang
    Lei, Lei
    Chen, Jia
    Ma, Shoubao
    Sun, Hongjian
    Yu, Di
    Han, Jingjing
    Xu, Yang
    Wu, Depei
    LEUKEMIA, 2025, 39 (02) : 473 - 481
  • [4] Hydroxychloroquine for the treatment of chronic graft-versus-host disease.
    Gilman, A
    Morris, C
    Mogul, M
    Mazumder, A
    Lee, CK
    Gingrich, R
    Goldman, F
    Trigg, M
    BLOOD, 1996, 88 (10) : 2421 - 2421
  • [5] Thalidomide for acute or chronic graft-versus-host disease.
    Kulkarni, S
    Powles, R
    Mehta, J
    Horton, C
    Treleaven, J
    Middleton, G
    Eisen, T
    Singhal, S
    BLOOD, 1996, 88 (10) : 2424 - 2424
  • [6] MOCRAVIMOD AMELIORATES CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER MOUSE ALLOGENEIC HSCT
    Zhang, Zixuan
    Hashimoto, Daigo
    Senjo, Hajime
    Li, Wenyu
    Yoneda, Kazuki
    Kikuchi, Ryo
    Chen, Xuanzhong
    Harada, Shinpei
    Saito, Yumika
    Miyajima, Toru
    Okada, Satomi
    Hasegawa, Yuta
    Ohigashi, Hiroyuki
    Ara, Takahide
    Dertschnig, Simone
    Teshima, Takanori
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 68 - 69
  • [7] Ocular graft-versus-host disease.
    Heffler, KF
    Grossman, H
    Marks, D
    Topolsky, D
    Styler, M
    Moul, J
    Crilley, P
    Brodsky, I
    BLOOD, 1995, 86 (10) : 3784 - 3784
  • [8] The experience and symptom burden of chronic graft-versus-host disease.
    Williams, Lori
    Couriel, Daniel
    Neumann, Joyce
    Whisenant, Meagan
    Galbizo, Ellaine
    Cleveland, Charles
    ONCOLOGY NURSING FORUM, 2007, 34 (01) : 212 - 212
  • [9] A Canine Model of Chronic Graft-versus-Host Disease
    Graves, Scott S.
    Rezvani, Andrew
    Sale, George
    Stone, Diane
    Parker, Maura
    Rosinski, Steven
    Spector, Michele
    Swearingen, Bruce
    Kean, Leslie
    Storb, Rainer
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : 420 - 427
  • [10] Ibrutinib treatment ameliorates murine chronic graft-versus-host disease
    Dubovsky, Jason A.
    Flynn, Ryan
    Du, Jing
    Harrington, Bonnie K.
    Zhong, Yiming
    Kaffenberger, Benjamin
    Yang, Carrie
    Towns, William H.
    Lehman, Amy
    Johnson, Amy J.
    Muthusamy, Natarajan
    Devine, Steven M.
    Jaglowski, Samantha
    Serody, Jonathan S.
    Murphy, William J.
    Munn, David H.
    Luznik, Leo
    Hill, Geoffrey R.
    Wong, Henry K.
    MacDonald, Kelli K. P.
    Maillard, Ivan
    Koreth, John
    Elias, Laurence
    Cutler, Corey
    Soiffer, Robert J.
    Antin, Joseph H.
    Ritz, Jerome
    Panoskaltsis-Mortari, Angela
    Byrd, John C.
    Blazar, Bruce R.
    JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (11): : 4867 - 4876
12345